4DX — 4DMedical Balance Sheet
0.000.00%
Last trade - 00:00- AU$817.02m
- AU$814.45m
- AU$5.85m
- 43
- 15
- 85
- 46
Annual balance sheet for 4DMedical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 80.9 | 51.1 | 69.6 | 30.6 | 6.88 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.99 | 6.37 | 6.96 | 5.89 | 7.44 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 85.8 | 58.9 | 78.5 | 39.1 | 17.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.82 | 10.4 | 9.26 | 8.75 | 7.47 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 92.6 | 74.3 | 92.9 | 120 | 94.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.17 | 9.56 | 17.1 | 21.9 | 19.3 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.28 | 14.8 | 21.5 | 49.1 | 30.6 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 83.4 | 59.5 | 71.5 | 70.9 | 64.2 |
| Total Liabilities & Shareholders' Equity | 92.6 | 74.3 | 92.9 | 120 | 94.8 |
| Total Common Shares Outstanding |